A bill that would pave the way for psychedelic-assisted therapy for veterans in Virginia is effectively dead for the session, with members of a House committee voting unanimously on Monday to set it aside indefinitely.
The 18–0 vote by the House Committee on Rules means no further action will happen this session on the measure, SB 1101, from Sen. Ghazala Hashmi (D).
In its latest form, the bill would have established a six-member state advisory council to study and make recommendations about treatments involving U.S. Food and Drug Administration (FDA)-designated “breakthrough therapies,” including substances such as psilocybin and MDMA.
Virginia’s full Senate approved the proposal unanimously earlier this month, on a 40–0 vote. But once it arrived in the House, the rules panel shelved it without debate or discussion.
As originally introduced, by Hashmi last month, the bill would have also created a fund to help pay for clinical trials into breakthrough therapy treatments for veterans, but a substitute adopted in a Senate committee removed references to that fund, leaving only the portion of the proposal that would create the advisory council.
“That particular substitute really pares the bill down to create within the Department of Health the Breakthrough Therapies for
Read full article on Marijuana Moment
